{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T21:36:54Z","timestamp":1774301814976,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K25 HL122305"],"award-info":[{"award-number":["K25 HL122305"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>While multiple randomized controlled trials (RCTs) are available, their results may not be generalizable to older, unhealthier or less-adherent patients. Observational data can be used to predict outcomes and evaluate treatments; however, exactly which strategy should be used to analyze the outcomes of treatment using observational data is currently unclear. This study aimed to determine the most accurate machine learning technique to predict 1-year-after-initial-acute-myocardial-infarction (AMI) survival of elderly patients and to identify the association of angiotensin-converting- enzyme inhibitors and angiotensin-receptor blockers (ACEi\/ARBs) with survival.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We built a cohort of 124,031 Medicare beneficiaries who experienced an AMI in 2007 or 2008. For analytical purposes, all variables were categorized into nine different groups: ACEi\/ARB use, demographics, cardiac events, comorbidities, complications, procedures, medications, insurance, and healthcare utilization. Our outcome of interest was 1-year-post-AMI survival. To solve this classification task, we used lasso logistic regression (LLR) and random forest (RF), and compared their performance depending on category selection, sampling methods, and hyper-parameter selection. Nested 10-fold cross-validation was implemented to obtain an unbiased estimate of performance evaluation. We used the area under the receiver operating curve (AUC) as our primary measure for evaluating the performance of predictive algorithms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>LLR consistently showed best AUC results throughout the experiments, closely followed by RF. The best prediction was yielded with LLR based on the combination of demographics, comorbidities, procedures, and utilization. The coefficients from the final LLR model showed that AMI patients with many comorbidities, older ages, or living in a low-income area have a higher risk of mortality 1-year after an AMI. In addition, treating the AMI patients with ACEi\/ARBs increases the 1-year-after-initial-AMI survival rate of the patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Given the many features we examined, ACEi\/ARBs were associated with increased 1-year survival among elderly patients after an AMI. We found LLR to be the best-performing model over RF to predict 1-year survival after an AMI. LLR greatly improved the generalization of the model by feature selection, which implicitly indicates the association between AMI-related variables and survival can be defined by a relatively simple model with a small number of features. Some comorbidities were associated with a greater risk of mortality, such as heart failure and chronic kidney disease, but others were associated with survival such as hypertension, hyperlipidemia, and diabetes. In addition, patients who live in urban areas and areas with large numbers of immigrants have a higher probability of survival. Machine learning methods are helpful to determine outcomes when RCT results are not available.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12911-022-01854-1","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T10:04:22Z","timestamp":1651226662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Machine learning approaches to predict the 1-year-after-initial-AMI survival of elderly patients"],"prefix":"10.1186","volume":"22","author":[{"given":"Jisoo","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sulyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Nick","family":"Street","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linnea A.","family":"Polgreen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"issue":"10","key":"1854_CR1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1161\/CIR.0000000000000485","volume":"135","author":"EJ Benjamin","year":"2017","unstructured":"Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, De Ferranti SD, Floyd J, Fornage M, Gillespie C, et al. Heart disease and stroke statistics-2017 update: a report from the American heart association. Circulation. 2017;135(10):146\u2013603.","journal-title":"Circulation"},{"issue":"3","key":"1854_CR2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jacc.2006.04.070","volume":"48","author":"CP Cannon","year":"2006","unstructured":"Cannon CP, Steinberg BA, Murphy SA, Mega JL, Braunwald E. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol. 2006;48(3):438\u201345.","journal-title":"J Am Coll Cardiol"},{"issue":"9535","key":"1854_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0140-6736(06)69201-5","volume":"368","author":"GR Dagenais","year":"2006","unstructured":"Dagenais GR, Pogue J, Fox K, Simoons ML, Yusuf S. Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: A combined analysis of three trials. The Lancet. 2006;368(9535):581\u20138.","journal-title":"The Lancet"},{"key":"1854_CR4","doi-asserted-by":"crossref","unstructured":"European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). The Lancet. 2003;362(9386):782\u20138","DOI":"10.1016\/S0140-6736(03)14286-9"},{"issue":"3","key":"1854_CR5","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","volume":"44","author":"SM Grundy","year":"2004","unstructured":"Grundy SM, Cleeman JI, Bairey Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. J Am Coll Cardiol. 2004;44(3):720\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"1854_CR6","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","volume":"333","author":"L K\u00f8ber","year":"1995","unstructured":"K\u00f8ber L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videb\u00e6k J, Cole DS, Auclert L, Pauly NC, et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1995;333(25):1670\u20136.","journal-title":"N Engl J Med"},{"issue":"10","key":"1854_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJM199209033271001","volume":"327","author":"MA Pfeffer","year":"1992","unstructured":"Pfeffer MA, Braunwald E, Moy\u00e9 LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial. N Engl J Med. 1992;327(10):669\u201377.","journal-title":"N Engl J Med"},{"issue":"20","key":"1854_CR8","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/NEJMoa032292","volume":"349","author":"MA Pfeffer","year":"2003","unstructured":"Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau J-L, K\u00f8ber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 2003;349(20):1893\u2013906.","journal-title":"N Engl J Med"},{"issue":"10","key":"1854_CR9","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1056\/NEJM199209033271002","volume":"327","author":"K Swedberg","year":"1992","unstructured":"Swedberg K, Held P, Kjekshus J, Rasmussen K, Ryd\u00e9n L, Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: results of the Cooperative New Scandinavian Enalapril Survival Study ii (CONSENSUS II). N Engl J Med. 1992;327(10):678\u201384.","journal-title":"N Engl J Med"},{"issue":"10","key":"1854_CR10","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1016\/j.jacc.2006.04.026","volume":"47","author":"SC Smith","year":"2006","unstructured":"Smith SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, et al. AHA\/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. J Am Coll Cardiol. 2006;47(10):2130\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"1854_CR11","doi-asserted-by":"crossref","unstructured":"Halimu C, Kasem A, Newaz SS. Empirical comparison of area under ROC curve (AUC) and Mathew correlation coefficient (MCC) for evaluating machine learning algorithms on imbalanced datasets for binary classification. In: Proceedings of the 3rd international conference on machine learning and soft computing; 2019. pp. 1\u20136","DOI":"10.1145\/3310986.3311023"},{"issue":"1","key":"1854_CR12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani R. Regression shrinkage and selection via the lasso. J Roy Stat Soc Ser B (Methodol). 1996;58(1):267\u201388.","journal-title":"J Roy Stat Soc Ser B (Methodol)"},{"issue":"3","key":"1854_CR13","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1002\/widm.1301","volume":"9","author":"P Probst","year":"2019","unstructured":"Probst P, Wright MN, Boulesteix A-L. Hyperparameters and tuning strategies for random forest. Wiley Interdiscip Rev Data Min Knowl Discov. 2019;9(3):1301.","journal-title":"Wiley Interdiscip Rev Data Min Knowl Discov"},{"key":"1854_CR14","volume-title":"Research paper in business analytics: feature selection with lasso","author":"V Fonti","year":"2017","unstructured":"Fonti V. Research paper in business analytics: feature selection with lasso. Amsterdam: VU Amsterdam; 2017."},{"issue":"1","key":"1854_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random forests. Mach Learn. 2001;45(1):5\u201332.","journal-title":"Mach Learn"},{"issue":"20","key":"1854_CR16","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1161\/CIRCULATIONAHA.115.001593","volume":"132","author":"RC Deo","year":"2015","unstructured":"Deo RC. Machine learning in medicine. Circulation. 2015;132(20):1920\u201330.","journal-title":"Circulation"},{"issue":"1","key":"1854_CR17","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/21642583.2014.956265","volume":"2","author":"K Fawagreh","year":"2014","unstructured":"Fawagreh K, Gaber MM, Elyan E. Random forests: from early developments to recent advancements. Syst Sci Control Eng Open Access J. 2014;2(1):602\u20139.","journal-title":"Syst Sci Control Eng Open Access J"},{"issue":"13","key":"1854_CR18","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1111\/1471-0528.15199","volume":"125","author":"E Hariton","year":"2018","unstructured":"Hariton E, Locascio JJ. Randomised controlled trials-the gold standard for effectiveness research. BJOG Int J Obstet Gynaecol. 2018;125(13):1716.","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"1854_CR19","unstructured":"Real-World Evidence. 2020. https:\/\/www.fda.gov\/science-research\/science-and-research-special-topics\/real-world-evidence. Accessed 1 July 2021"},{"key":"1854_CR20","first-page":"204","volume":"2012","author":"J Vomlel","year":"2012","unstructured":"Vomlel J, Kruz\u0131k H, Tuma P, Precek J, Hutyra M. Machine learning methods for mortality prediction in patients with ST elevation myocardial infarction. Proc WUPES. 2012;2012:204\u201313.","journal-title":"Proc WUPES"},{"key":"1854_CR21","first-page":"407","volume":"2019","author":"LA Barrett","year":"2019","unstructured":"Barrett LA, Payrovnaziri SN, Bian J, He Z. Building computational models to predict one-year mortality in ICU patients with acute myocardial infarction and post myocardial infarction syndrome. AMIA Summits Transl Sci Proc. 2019;2019:407.","journal-title":"AMIA Summits Transl Sci Proc"},{"issue":"1","key":"1854_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"W Lee","year":"2021","unstructured":"Lee W, Lee J, Woo S-I, Choi SH, Bae J-W, Jung S, Jeong MH, Lee WK. Machine learning enhances the performance of short and long-term mortality prediction model in non-ST-segment elevation myocardial infarction. Sci Rep. 2021;11(1):1\u201314.","journal-title":"Sci Rep"},{"issue":"3","key":"1854_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1467-9868.2011.00771.x","volume":"73","author":"R Tibshirani","year":"2011","unstructured":"Tibshirani R. Regression shrinkage and selection via the lasso: a retrospective. J R Stat Soc Ser B (Stat Methodol). 2011;73(3):273\u201382.","journal-title":"J R Stat Soc Ser B (Stat Methodol)"},{"key":"1854_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-7138-7","volume-title":"An introduction to statistical learning with applications in R","author":"G James","year":"2013","unstructured":"James G, Witten D, Hastie T, Tibshirani R. An introduction to statistical learning with applications in R. Berlin: Spinger; 2013."},{"issue":"23","key":"1854_CR25","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1161\/CIRCULATIONAHA.104.496174","volume":"111","author":"C Tonne","year":"2005","unstructured":"Tonne C, Schwartz J, Mittleman M, Melly S, Suh H, Goldberg R. Long-term survival after acute myocardial infarction is lower in more deprived neighborhoods. Circulation. 2005;111(23):3063\u201370.","journal-title":"Circulation"},{"issue":"1","key":"1854_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-020-01689-5","volume":"18","author":"ME Yadegarfar","year":"2020","unstructured":"Yadegarfar ME, Gale CP, Dondo TB, Wilkinson CG, Cowie MR, Hall M. Association of treatments for acute myocardial infarction and survival for seven common comorbidity states: A nationwide cohort study. BMC Med. 2020;18(1):1\u201312.","journal-title":"BMC Med"},{"issue":"Suppl-1","key":"1854_CR27","first-page":"14662","volume":"140","author":"LA Polgreen","year":"2019","unstructured":"Polgreen LA, Street WN, Lee S. Treatment combinations for elderly patients and those with comorbidities after an acute myocardial infarction. Circulation. 2019;140(Suppl-1):14662\u201314662.","journal-title":"Circulation"},{"key":"1854_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ijcard.2018.02.079","volume":"259","author":"R Shvartsur","year":"2018","unstructured":"Shvartsur R, Shiyovich A, Gilutz H, Azab AN, Plakht Y. Short and long-term prognosis following acute myocardial infarction according to the country of origin. Soroka Acute Myocardial Infarction II (SAMI II) project. Int J Cardiol. 2018;259:227\u201333.","journal-title":"Int J Cardiol"},{"issue":"7","key":"1854_CR29","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10654-015-0024-7","volume":"31","author":"S Byberg","year":"2016","unstructured":"Byberg S, Agyemang C, Zwisler AD, Krasnik A, Norredam M. Cardiovascular disease incidence and survival: are migrants always worse off? Eur J Epidemiol. 2016;31(7):667\u201377.","journal-title":"Eur J Epidemiol"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-022-01854-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-022-01854-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-022-01854-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T08:50:26Z","timestamp":1727081426000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-022-01854-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1854"],"URL":"https:\/\/doi.org\/10.1186\/s12911-022-01854-1","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"assertion":[{"value":"30 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study (#201506840) was approved by the University of Iowa Institutional Review Board (HawkIRB). An informed consent waiver was granted by HawkIRB, and all methods were performed in accordance with institutional guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}